MI-463

CAS No. 1628317-18-9

MI-463 ( MI463;MI 463 )

Catalog No. M12428 CAS No. 1628317-18-9

MI-463 is a highly potent and orally bioavailable small-molecule inhibitor of menin–MLL.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 Get Quote
10MG 140 Get Quote
25MG 250 Get Quote
50MG 357 Get Quote
100MG 484 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MI-463
  • Note
    Research use only, not for human use.
  • Brief Description
    MI-463 is a highly potent and orally bioavailable small-molecule inhibitor of menin–MLL.
  • Description
    MI-463 is a highly potent and orally bioavailable small-molecule inhibitor of menin–MLL (IC50=15.3 nM; Kd=9.9 nM); shows profound effects in MLL leukemia cells and substantial survival benefit in mouse models of MLL leukemia.
  • Synonyms
    MI463;MI 463
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    HMTase
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1628317-18-9
  • Formula Weight
    484.54
  • Molecular Formula
    C24H23F3N6S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC1=C2C(NC(C#N)=C2)=CC=C1CN(CC3)CCC3NC4=C(C=C(CC(F)(F)F)S5)C5=NC=N4
  • Chemical Name
    1H-Indole-2-carbonitrile, 4-methyl-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Borkin D, et al. Cancer Cell. 2015 Apr 13;27(4):589-602.
molnova catalog
related products
  • EPZ6438

    EPZ-6438 is a potent, and selective EZH2 inhibitor with Ki and IC50 of 2.5 nM and 11 nM in cell-free assays.

  • BIX 01294 Trihydroch...

    BIX01294 is an inhibitor of G9a histone methyltransferase with IC50 of 2.7 μM in a cell-free assay.

  • MI-463

    MI-463 is a highly potent and orally bioavailable small-molecule inhibitor of menin–MLL.